GGrantIndex
Sort

16,300 grants matching fatty liver disease

Manipulation of the gut microbiome to delay breast cancer onset and progression in the context of weight loss and obesity

$29,283
Margaret Sue Bohm · University Of Tennessee Health Sci Ctr · F31 · FY2025 · CA

GLUCOSE AND LIPID METABOLISM ON ANTIPSYCHOTIC MEDICATION

$29,280
John W. Newcomer · Washington University · M01 · FY2007 · RR

Understanding the role of O-GlcNAcylation in regulating cancer lipid metabolism

$29,280
Valerie Sodi Salvatico · Drexel University · F31 · FY2016 · CA

Metabolic defects in mice with adipocyte-specific deletion of Akt2

$29,208
Abigail Shearin · University Of Pennsylvania · F30 · FY2014 · DK

The Role of Akt2 in Hepatic Lipid Metabolism

$29,207
Karla Fitzgerald Leavens · University Of Pennsylvania · F30 · FY2011 · DK

Disruption of Domain Communication in LRH-1 via SUMOylation

$29,206
Corey Seacrist · Vanderbilt University · F31 · FY2018 · DK

Liver Triglyceride Metabolism in Non-alcoholic Steatohepatitis (NASH)

$29,202
University Of Minnesota Twin Cities · M01 · FY2004 · RR

Targeting osteopontin as a regulator of macrophage infiltration and inflammation.

$29,190
Joseph Chrispin Yawe · Univ Of Massachusetts Med Sch Worcester · F31 · FY2014 · DK

Clinical/Laboratory Training Academic Gastroenterology

$29,183
Nicholas Davidson · Washington University · T32 · FY2007 · DK

Exploratory Project: 1 Mitochondrial Phospholipid Oxidation in Alcoholic Liver

$29,132
Ariel Feldstein · Cleveland Clinic Lerner Com-Cwru · P20 · FY2013 · AA

Role of the Gut Microbiome in Polycystic Ovary Syndrome

$29,107
Varykina G Thackray · University Of California, San Diego · R01 · FY2021 · HD

The Role of Apolipoprotein A-V in Chylomicron Metabolism

$29,016
Xenia Danae Davis · University Of Cincinnati · F31 · FY2019 · DK

Fatty acid metabolism and DGAT1 deficiency

$28,916
J. David Gladstone Institutes · F31 · FY2005 · DK

The role of cAMP signaling changes in alcoholic liver disease

$28,894
Victoria Lyell Prince · Univ Of Med/Dent Of Nj-Nj Medical School · F30 · FY2010 · AA

Dissecting the role of hepatic macrophages in progressive NASH

$28,894
Annie Joseph Kruger · Massachusetts General Hospital · F32 · FY2018 · DK

PD-L1 reverse signaling in liver homeostasis and disease

$28,803
Beth Ann Tamburini · University Of Colorado Denver · R01 · FY2025 · AI

Metabolic Syndrome--Prepubertal African Amer./Caucasian

$28,802
Melinda S Sothern · Lsu Health Sciences Center · R01 · FY2009 · HD

The Role of Akt2 in Hepatic Lipid Metabolism

$28,787
Karla Fitzgerald Leavens · University Of Pennsylvania · F30 · FY2010 · DK

Race/Ethnic Specific Association Between Anthropometry, Liver Fat and Incident Type 2 Diabetes: Evidence from The Multi-Ethnic Study of Atherosclerosis

$28,785
Luis A Rodriguez · University Of California, San Francisco · F31 · FY2020 · DK

Metabolic defects in mice with adipocyte-specific deletion of Akt2

$28,764
Abigail Shearin · University Of Pennsylvania · F30 · FY2013 · DK

Understanding the molecular regulation of autophagy during aging

$28,750
Rajat Singh · Albert Einstein College Of Medicine, Inc · R21 · FY2018 · AG

Targeting osteopontin as a regulator of macrophage infiltration and inflammation.

$28,746
Joseph Chrispin Yawe · Univ Of Massachusetts Med Sch Worcester · F31 · FY2012 · DK

The Role of Hepatic Integrin-Linked Kinase in Health and Insulin Resistance

$28,723
Elijah Trefts · Vanderbilt University · F31 · FY2017 · DK

Apolipoprotein AV and intestinal transport

$28,721
Patrick Powing Tso · University Of Cincinnati · R01 · FY2017 · DK

The role of cAMP signaling changes in alcoholic liver disease

$28,690
Victoria Lyell Prince · Univ Of Med/Dent Of Nj-Nj Medical School · F30 · FY2009 · AA